For example, nonalcoholic fatty liver disease (NAFLD) is pathologically known for metabolic dysregulation, to the point where it was recently renamed as metabolic dysfunction-associated fatty liver disease (MAFLD) and is known to involve the PPAR signaling pathway along with HCC [33,34]. The gene discussed is PPARA; the disease is hepatocellular carcinoma.